BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/21/2020 1:38:19 AM | Browse: 689 | Download: 1086
 |
Received |
|
2020-02-28 20:44 |
|
Peer-Review Started |
|
2020-02-28 20:49 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-04-29 19:13 |
|
Revised |
|
2020-05-18 11:29 |
|
Second Decision |
|
2020-06-09 08:47 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-06-10 20:01 |
|
Articles in Press |
|
2020-06-10 20:01 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-06-24 09:20 |
|
Typeset the Manuscript |
|
2020-07-30 14:04 |
|
Publish the Manuscript Online |
|
2020-08-21 01:38 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Review |
| Article Title |
Statins in risk-reduction and treatment of cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Cristina I Barbalata, Lucia R Tefas, Marcela Achim, Ioan Tomuta and Alina S Porfire |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Alina S Porfire, PhD, Associate Professor, Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, “Iuliu- Hatieganu” University of Medicine and Pharmacy, 41 Victor Babes, Cluj-Napoca 400012, Romania. aporfire@umfcluj.ro |
| Key Words |
Statins; Cancer; Pleiotropic effects; Risk reduction; Clinical trials; 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase |
| Core Tip |
In the last period, statins have been increasingly studied for their anticancer properties. This review presents the application of statins in cancer management by outlining the latest in vitro and in vivo studies. The results represent the foundation of the latest clinical trials in order to search for new treatment directions in cancer therapy. |
| Publish Date |
2020-08-21 01:38 |
| Citation |
Barbalata CI, Tefas LR, Achim M, Tomuta I, Porfire AS. Statins in risk-reduction and treatment of cancer. World J Clin Oncol 2020; 11(8): 573-588 |
| URL |
https://www.wjgnet.com/2218-4333/full/v11/i8/573.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v11.i8.573 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
